Eckert & Ziegler stock gains 0.93% to EUR 15.12 premarket
Published on 11/19/2026 at 08:40 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSWhat Investors Should Watch
- Eckert & Ziegler serves medical, scientific and measurement applications with isotope technology components.
- The company reported 2025 revenue of EUR 312.0 million and adjusted EBIT of EUR 77.7 million.
Eckert & Ziegler stock traded at EUR 15.12 on Lang & Schwarz at 08:37 CET on Thursday, November 19, 2026, 0.93 percent above the Xetra close of Wednesday, November 18, 2026, as reported by Yahoo Finance.
The group focuses on isotope technology for cancer treatment, industrial radiometry, and nuclear medicine diagnostics and therapy, according to Eckert & Ziegler investor relations.
German equities remain in focus alongside current market reports.
Disclaimer...
en | DE0005659700 | ECKERT & ZIEGLER | boerse | 70534506 | bgmi
